Overview

Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo

Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure carotid artery IMT at a single visit in a subset of women previously enrolled in the CORE (H3S-MC-GGJY) trial
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Raloxifene Hydrochloride